TerminatedPhase 3NCT03689244
A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment
Studying Chronic thromboembolic pulmonary hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Actelion
- Principal Investigator
- Julian Borissoff, MD, PhDActelion
- Intervention
- Selexipag(drug)
- Enrollment
- 128 enrolled
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2019 – 2022
Study locations (30)
- University of California San Diego Medical Center, La Jolla, California, United States
- University of Southern California, Keck School of Medicine, Los Angeles, California, United States
- University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
- Colorado Springs Pulmonary Consultants, Colorado Springs, Colorado, United States
- South Denver Cardiology Associates PC, Littleton, Colorado, United States
- Mayo Clinic in Florida, Jacksonville, Florida, United States
- Piedmont Healthcare, Atlanta, Georgia, United States
- Emory University, Atlanta, Georgia, United States
- Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
- University of Chicago Hospitals - Chicago, Chicago, Illinois, United States
- Advocate Christ Medical Center, Oak Lawn, Illinois, United States
- University of Maryland, Baltimore, Maryland, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Sparrow Clinical Research Institute, Lansing, Michigan, United States
- Mayo Clinic, Rochester, Minnesota, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03689244 on ClinicalTrials.govOther trials for Chronic thromboembolic pulmonary hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07522203Arterial Wave Energy Flux and Multidimensional Recovery in Patients With Chronic Thromboembolic Pulmonary Hypertension Undergoing Balloon Pulmonary AngioplastyIstanbul Mehmet Akif Ersoy Educational and Training Hospital
- RECRUITINGNCT07272798Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary HypertensionDamascus University
- RECRUITINGNCT07299227Impact of BPA in CTEPH on Cardiac and Pulmonary Physiology Assessed by CMR-derived 4D Flow HaemodynamicsKerckhoff Klinik
- RECRUITINGNCT07217522Rutgers University Study of the Genetics of Pulmonary HypertensionRutgers, The State University of New Jersey
- RECRUITINGNCT07254078Registry of Patients With chrOnic thromboemboLic Pulmonary hypErTensionIrina E. Chazova
- RECRUITINGPHASE3NCT06922240Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)Suqiao Yang
- RECRUITINGPHASE3NCT05140525Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPHDr Sudarshan Rajagopal
- RECRUITINGNCT06081881Chronic Thromboembolic Pulmonary Hypertension After Pulmonary EmbolismEster Ashraf Faried Beshay
See all trials for Chronic thromboembolic pulmonary hypertension →